Search research articles
Contact Us
Filters
Showing results (101-110 of 154) with videos related to
Page
of 16
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
October 19, 2012
What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes
Christopher Ll Morgan, Chris D Poole, Marc Evans, et al.
Clinical Kidney Journal
|
April 4, 2022
Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study
Glen James, Jennifer Kim, Carl Mellström, et al.
BMC Nephrology
|
August 24, 2018
Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink
Hans Furuland, Phil McEwan, Marc Evans, et al.
ESC Heart Failure
|
January 11, 2019
Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK
Cecilia Linde, Lei Qin, Ameet Bakhai, et al.
Journal of Medical Economics
|
November 23, 2017
An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin
Marc Evans, Liana K Billings, Jonas Håkan-Bloch, et al.
Infection and Immunity
|
March 24, 2010
Association of pathogen strain-specific gene transcription and transmission efficiency phenotype of Anaplasma marginale
Joseph T Agnes, David Herndon, Massaro W Ueti, et al.
Advances in Therapy
|
January 12, 2021
Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review
Oliver Darlington, Carissa Dickerson, Marc Evans, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 27, 2025
Practical Approaches to Continuous Glucose Monitoring in Primary Care: A UK-Based Consensus Opinion
Kevin Fernando, Vicki Alabraba, John B Welsh, et al.
Patient Preference and Adherence
|
October 3, 2013
Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective
Stewart B Harris, Kamlesh Khunti, Mona Landin-Olsson, et al.
Biochemical and Biophysical Research Communications
|
June 14, 2005
The PPAR-gamma activator, Rosiglitazone, inhibits actin polymerisation in monocytes: involvement of Akt and intracellular calcium
Neenu Singh, Richard Webb, Rachel Adams, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 154) with videos related to
Sort By:
Page
of 16
The Journal of Clinical Endocrinology and Metabolism
|
October 19, 2012
What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes
Christopher Ll Morgan, Chris D Poole, Marc Evans, et al.
Clinical Kidney Journal
|
April 4, 2022
Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study
Glen James, Jennifer Kim, Carl Mellström, et al.
BMC Nephrology
|
August 24, 2018
Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink
Hans Furuland, Phil McEwan, Marc Evans, et al.
ESC Heart Failure
|
January 11, 2019
Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK
Cecilia Linde, Lei Qin, Ameet Bakhai, et al.
Journal of Medical Economics
|
November 23, 2017
An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin
Marc Evans, Liana K Billings, Jonas Håkan-Bloch, et al.
Infection and Immunity
|
March 24, 2010
Association of pathogen strain-specific gene transcription and transmission efficiency phenotype of Anaplasma marginale
Joseph T Agnes, David Herndon, Massaro W Ueti, et al.
Advances in Therapy
|
January 12, 2021
Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review
Oliver Darlington, Carissa Dickerson, Marc Evans, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 27, 2025
Practical Approaches to Continuous Glucose Monitoring in Primary Care: A UK-Based Consensus Opinion
Kevin Fernando, Vicki Alabraba, John B Welsh, et al.
Patient Preference and Adherence
|
October 3, 2013
Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective
Stewart B Harris, Kamlesh Khunti, Mona Landin-Olsson, et al.
Biochemical and Biophysical Research Communications
|
June 14, 2005
The PPAR-gamma activator, Rosiglitazone, inhibits actin polymerisation in monocytes: involvement of Akt and intracellular calcium
Neenu Singh, Richard Webb, Rachel Adams, et al.
Page
of 16